Egyptian Drug Authority · Egypt
DEA-EG-2026-0070
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- report no.(70) For 2026V
- Date issued
- Jul 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Tagrisso 80 mg film-coated tablets
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Tagrisso 80 mg film-coated tablets
AstraZenecaالشركة المصنعة
FEST
06\2025- 05\2028
وذلك بناءً على ما ورد الينا من من شركة
AstraZeneca صاحبة المستحضر حيث افادت ان
العبوات بالبيانات الموضحة بعاليه لا تخصها و لم
يتم تصنيعها بمعرفتها, حيث يمكن تمييزالعبوات
مجهولة المصدر كما هو موضح بالرابط
ضبط وتحريز العبوات الغير مطابقة للمواصفات
من المستحضر طبقا لما هو وارد بالرابط
في حالة الشك في المستحضر الصيدلى يتم الرجوع
الى هيئة الدواء المصرية سواء بالإتصال بالخط
الساخن 15301او الموقع الإلكترونى الخاص بالهيئة.
يمكن الضغط على الرابطللإطلاع على الصور
الخاصة بالمستحضر المقلد.
يوليو 2026
منشور
غش تجاري
اسم المستحضر
سبب التحذير
الإجراءات التصحيحية
نصائح
للمستهلكين
هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على
تداول المستحضر بشكل عام
رقم التشغيلة
تاريخ الانتاج و الانتهاءOriginal language: ar
- Notice text in English
- Notice. Tagrisso 80 mg film-coated tablets, manufactured by AstraZeneca, batch FEST, dated 06/2025 to 05/2028. On the basis of what AstraZeneca, which owns the product, reported to the Authority about the packs bearing the particulars set out above.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Primary source
- https://www.edaegypt.gov.eg/media/tklnmmg0/tagrisso-2125-%D8%BA%D8%B4-%D8%AA%D8%AC%D8%A7%D8%B1%D9%8A.pdf
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- bc2fc0ae2bd96d00e8eb357455fc2e42255d650d03437287d8c9e19fb0b7a6b8SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:50:44 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0070: Tagrisso 80 mg film-coated tablets — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0070Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.